Lifestyle and age-related macular degeneration

References

• Klein R, Wang Q, Klein BE et al. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest. Ophthalmol. Vis. Sci.36(1), 182–191 (1995).
   PubMed Web of Science ®Google Scholar
• Attebo K, Mitchell P, Smith W. Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study. Ophthalmology103(3), 357–364 (1996).
   PubMed Web of Science ®Google Scholar
• Klaver CC, Wolfs RC, Vingerling JR et al. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch. Ophthalmol.116(5), 653–658 (1998).
   PubMed Web of Science ®Google Scholar
• Chan CW, Billson FA. Visual disability and major causes of blindness in NSW: a study of people aged 50 and over attending the Royal Blind Society 1984 to 1989. Aust. NZ J. Ophthalmol.19(4), 321–325 (1991).
   PubMedGoogle Scholar
• Friedman DS, O’Colmain BJ, Munoz B et al. Prevalence of age-related macular degeneration in the United States. Arch. Ophthalmol.122(4), 564–572 (2004).
   PubMed Web of Science ®Google Scholar
• McCarty CA, Wright S, McKay R et al. Changes in management of diabetic retinopathy by Australian ophthalmologists as a result of the NHMRC clinical guidelines. Clin. Exp. Ophthalmol.29(4), 230–234 (2001).
   PubMedGoogle Scholar
• Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology102(10), 1450–1460 (1995).
   PubMed Web of Science ®Google Scholar
• Rosenfeld PJ, Brown DM, Heier JS et al. Ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med.355(14), 1419–1431 (2006).
   PubMed Web of Science ®Google Scholar
• Brown DM, Kaiser PK, Michels M et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N. Engl. J. Med.355(14), 1432–1444 (2006).
   PubMed Web of Science ®Google Scholar
• Edwards AO, Ritter R 3rd, Abel KJ et al. Complement factor H polymorphism and age-related macular degeneration. Science308(5720), 421–424 (2005).
   PubMed Web of Science ®Google Scholar
• Klein RJ, Zeiss C, Chew EY et al. Complement factor H polymorphism in age-related macular degeneration. Science308(5720), 385–389 (2005).
   PubMed Web of Science ®Google Scholar
• Haines JL, Hauser MA, Schmidt S et al. Complement factor H variant increases the risk of age-related macular degeneration. Science308(5720), 419–421 (2005).
   PubMed Web of Science ®Google Scholar
• Gold B, Merriam JE, Zernant J et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat. Genet.38(4), 458–462 (2006).
   PubMed Web of Science ®Google Scholar
• Maller JB, Fagerness JA, Reynolds RC et al. Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat. Genet.39(10), 1200–1201 (2007).
   PubMed Web of Science ®Google Scholar
• Spencer KL, Hauser MA, Olson LM et al. Deletion of CFHR3 and CFHR1 genes in age-related macular degeneration. Hum. Mol. Genet.17(7), 971–977 (2008).
   PubMed Web of Science ®Google Scholar
• Yang Z, Camp NJ, Sun H et al. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science314(5801), 992–993 (2006).
   PubMed Web of Science ®Google Scholar
• Dewan A, Liu M, Hartman S et al.HTRA1 promoter polymorphism in wet age-related macular degeneration. Science314(5801), 989–992 (2006).
   PubMed Web of Science ®Google Scholar
• Jakobsdottir J, Conley YP, Weeks DE et al. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am. J. Hum. Genet.77(3), 389–407 (2005).
   PubMed Web of Science ®Google Scholar
• Klaver CC, Kliffen M, van Duijn CM et al. Genetic association of apolipoprotein E with age-related macular degeneration. Am. J. Hum. Genet.63(1), 200–206 (1998).
   PubMed Web of Science ®Google Scholar
• Baird PN, Richardson AJ, Robman LD et al. Apolipoprotein (APOE) gene is associated with progression of age-related macular degeneration (AMD). Hum. Mutat.27(4), 337–342 (2006).
   PubMed Web of Science ®Google Scholar
• Thakkinstian A, Han P, McEvoy M et al. Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration. Hum. Mol. Genet.15(18), 2784–2790 (2006).
   PubMed Web of Science ®Google Scholar
• Thornton J, Edwards R, Mitchell P et al. Smoking and age-related macular degeneration: a review of association. Eye19(9), 935–944 (2005).
   PubMed Web of Science ®Google Scholar
• Risk factors for neovascular age-related macular degeneration. The Eye Disease Case–control Study Group. Arch. Ophthalmol.110(12), 1701–1708 (1992).
   PubMed Web of Science ®Google Scholar
• Risk factors associated with age-related macular degeneration. A case–control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology107(12), 2224–2232 (2000).
   PubMed Web of Science ®Google Scholar
• Christen WG, Glynn RJ, Manson JE et al. A prospective study of cigarette smoking and risk of age-related macular degeneration in men. JAMA276(14), 1147–1151 (1996).
   PubMed Web of Science ®Google Scholar
• Delcourt C, Diaz JL, Ponton-Sanchez A, Papoz L. Smoking and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liees a l’Age. Arch. Ophthalmol.116(8), 1031–1035 (1998).
   PubMedGoogle Scholar
• Klein R, Klein BE, Linton KL, DeMets DL. The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Am. J. Epidemiol.137(2), 190–200 (1993).
   PubMed Web of Science ®Google Scholar
• McCarty CA, Mukesh BN, Fu CL et al. Risk factors for age-related maculopathy: the Visual Impairment Project. Arch. Ophthalmol.119(10), 1455–1462 (2001).
   PubMed Web of Science ®Google Scholar
• Mitchell P, Wang JJ, Smith W, Leeder SR. Smoking and the 5-year incidence of age-related maculopathy: the Blue Mountains Eye Study. Arch. Ophthalmol.120(10), 1357–1363 (2002).
   PubMed Web of Science ®Google Scholar
• Seddon JM, Willett WC, Speizer FE, Hankinson SE. A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA276(14), 1141–1146 (1996).
   PubMed Web of Science ®Google Scholar
• Smith W, Mitchell P, Leeder SR. Smoking and age-related maculopathy. The Blue Mountains Eye Study. Arch. Ophthalmol.114(12), 1518–1523 (1996).
   PubMedGoogle Scholar
• Tamakoshi A, Yuzawa M, Matsui M et al. Smoking and neovascular form of age related macular degeneration in late middle aged males: findings from a case–control study in Japan. Research Committee on Chorioretinal Degenerations. Br. J. Ophthalmol.81(10), 901–904 (1997).
   PubMedGoogle Scholar
• Vinding T, Appleyard M, Nyboe J, Jensen G. Risk factor analysis for atrophic and exudative age-related macular degeneration. An epidemiological study of 1000 aged individuals. Acta Ophthalmol. (Copenh.)70(1), 66–72 (1992).
   Google Scholar
• Vingerling JR, Hofman A, Grobbee DE, de Jong PT. Age-related macular degeneration and smoking. The Rotterdam Study. Arch. Ophthalmol.114(10), 1193–1196 (1996).
   PubMedGoogle Scholar
• Blumenkranz MS, Russell SR, Robey MG et al. Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology93(5), 552–558 (1986).
   PubMed Web of Science ®Google Scholar
• Chaine G, Hullo A, Sahel J et al. Case–control study of the risk factors for age related macular degeneration. France-DMLA Study Group. Br. J. Ophthalmol.82(9), 996–1002 (1998).
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE. Relation of smoking to the incidence of age-related maculopathy. The Beaver Dam Eye Study. Am. J. Epidemiol.147(2), 103–110 (1998).
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Tomany SC, Moss SE. Ten-year incidence of age-related maculopathy and smoking and drinking: the Beaver Dam Eye Study. Am. J. Epidemiol.156(7), 589–598 (2002).
   PubMed Web of Science ®Google Scholar
• West SK, Rosenthal FS, Bressler NM et al. Exposure to sunlight and other risk factors for age-related macular degeneration. Arch. Ophthalmol.107(6), 875–879 (1989).
   PubMed Web of Science ®Google Scholar
• Smith W, Assink J, Klein R et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology108(4), 697–704 (2001).
   PubMed Web of Science ®Google Scholar
• Klein R, Knudtson MD, Cruickshanks KJ, Klein BE. Further observations on the association between smoking and the long-term incidence and progression of age-related macular degeneration: the Beaver Dam Eye Study. Arch. Ophthalmol.126(1), 115–121 (2008).
   PubMedGoogle Scholar
• Suner IJ, Espinosa-Heidmann DG, Marin-Castano ME et al. Nicotine increases size and severity of experimental choroidal neovascularization. Invest. Ophthalmol. Vis. Sci.45(1), 311–317 (2004).
   PubMed Web of Science ®Google Scholar
• Beatty S, Koh H, Phil M et al. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol.45(2), 115–134 (2000).
   PubMed Web of Science ®Google Scholar
• Whitehead AJ, Mares JA, Danis RP. Macular pigment: a review of current knowledge. Arch. Ophthalmol.124(7), 1038–1045 (2006).
   PubMed Web of Science ®Google Scholar
• Hammond BR Jr, Caruso-Avery M. Macular pigment optical density in a Southwestern sample. Invest. Ophthalmol. Vis. Sci.41(6), 1492–1497 (2000).
   PubMed Web of Science ®Google Scholar
• Hammond BR Jr, Wooten BR, Snodderly DM. Cigarette smoking and retinal carotenoids: implications for age-related macular degeneration. Vision Res.36(18), 3003–3009 (1996).
   PubMed Web of Science ®Google Scholar
• Nolan JM, Stack J, O’Donovan O et al. Risk factors for age-related maculopathy are associated with a relative lack of macular pigment. Exp. Eye Res.84(1), 61–74 (2007).
   PubMed Web of Science ®Google Scholar
• Sastry BV, Hemontolor ME. Influence of nicotine and cotinine on retinal phospholipase A2 and its significance to macular function. J. Ocul. Pharmacol. Ther.14(5), 447–458 (1998).
   PubMedGoogle Scholar
• Patton WP, Routledge MN, Jones GD et al. Retinal pigment epithelial cell DNA is damaged by exposure to benzo[a]pyrene, a constituent of cigarette smoke. Exp. Eye Res.74(4), 513–522 (2002).
   PubMedGoogle Scholar
• Bok D. Evidence for an inflammatory process in age-related macular degeneration gains new support. Proc. Natl Acad. Sci. USA102(20), 7053–7054 (2005).
   PubMed Web of Science ®Google Scholar
• Hageman GS, Anderson DH, Johnson LV et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl Acad. Sci. USA102(20), 7227–7232 (2005).
   PubMed Web of Science ®Google Scholar
• Zareparsi S, Branham KE, Li M et al. Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am. J. Hum. Genet.77(1), 149–153 (2005).
   PubMed Web of Science ®Google Scholar
• Kew RR, Ghebrehiwet B, Janoff A. Cigarette smoke can activate the alternative pathway of complement in vitro by modifying the third component of complement. J. Clin. Invest.75(3), 1000–1007 (1985).
   PubMed Web of Science ®Google Scholar
• Maresh JG, Xu H, Jiang N et al. Tobacco smoke dysregulates endothelial vasoregulatory transcripts in vivo. Physiol. Genomics21(3), 308–313 (2005).
   PubMedGoogle Scholar
• Schmidt S, Hauser MA, Scott WK et al. Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am. J. Hum. Genet.78(5), 852–864 (2006).
   PubMed Web of Science ®Google Scholar
• Ciulla TA, Harris A, Kagemann L et al. Choroidal perfusion perturbations in non-neovascular age related macular degeneration. Br. J. Ophthalmol.86(2), 209–213 (2002).
   PubMed Web of Science ®Google Scholar
• Lutty G, Grunwald J, Majji AB et al. Changes in choriocapillaris and retinal pigment epithelium in age-related macular degeneration. Mol. Vis.5, 35 (1999).
   PubMed Web of Science ®Google Scholar
• Ciulla TA, Harris A, Chung HS et al. Color Doppler imaging discloses reduced ocular blood flow velocities in nonexudative age-related macular degeneration. Am. J. Ophthalmol.128(1), 75–80 (1999).
   PubMed Web of Science ®Google Scholar
• Uretmen O, Akkin C, Erakgun T, Killi R. Color Doppler imaging of choroidal circulation in patients with asymmetric age-related macular degeneration. Ophthalmologica217(2), 137–142 (2003).
   PubMedGoogle Scholar
• Solberg Y, Rosner M, Belkin M. The association between cigarette smoking and ocular diseases. Surv. Ophthalmol.42(6), 535–547 (1998).
   PubMed Web of Science ®Google Scholar
• Seddon JM, Rosner B, Sperduto RD et al. Dietary fat and risk for advanced age-related macular degeneration. Arch. Ophthalmol.119(8), 1191–1199 (2001).
   PubMed Web of Science ®Google Scholar
• Seddon JM, Cote J, Rosner B. Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake. Arch. Ophthalmol.121(12), 1728–1737 (2003).
   PubMed Web of Science ®Google Scholar
• Hyman L, Schachat AP, He Q, Leske MC. Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. Arch. Ophthalmol.118(3), 351–358 (2000).
   PubMed Web of Science ®Google Scholar
• Chakravarthy U, Augood C, Bentham GC et al. Cigarette smoking and age-related macular degeneration in the EUREYE Study. Ophthalmology114(6), 1157–1163 (2007).
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Franke T. The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology100(3), 406–414 (1993).
   PubMed Web of Science ®Google Scholar
• Klein R, Deng Y, Klein BE et al. Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women’s Health Initiative Sight Exam ancillary study. Am. J. Ophthalmol.143(3), 473–483 (2007).
   PubMed Web of Science ®Google Scholar
• Guymer RH, Chong EW. Modifiable risk factors for age-related macular degeneration. Med. J. Aust.184(9), 455–458 (2006).
   PubMed Web of Science ®Google Scholar
• Sato E, Feke GT, Appelbaum EY et al. Association between systemic arterial stiffness and age-related macular degeneration. Graefes Arch. Clin. Exp. Ophthalmol.244(8), 963–971 (2006).
   PubMedGoogle Scholar
• Snow KK, Seddon JM. Do age-related macular degeneration and cardiovascular disease share common antecedents? Ophthalmic. Epidemiol.6(2), 125–143 (1999).
   PubMedGoogle Scholar
• Tikellis G, Robman LD, Dimitrov P et al. Characteristics of progression of early age-related macular degeneration: the cardiovascular health and age-related maculopathy study. Eye21(2), 169–176 (2007).
   PubMed Web of Science ®Google Scholar
• Wong TY, Klein R, Sun C et al. Age-related macular degeneration and risk for stroke. Ann. Intern. Med.145(2), 98–106 (2006).
   PubMed Web of Science ®Google Scholar
• Sivaprasad S, Bailey TA, Chong VN. Bruch’s membrane and the vascular intima: is there a common basis for age-related changes and disease? Clin. Exp. Ophthalmol.33(5), 518–523 (2005).
   PubMedGoogle Scholar
• Ascherio A, Rimm EB, Giovannucci EL et al. Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States. BMJ313(7049), 84–90 (1996).
   PubMed Web of Science ®Google Scholar
• Cheung N, Liao D, Islam FM et al. Is early age-related macular degeneration related to carotid artery stiffness? The Atherosclerosis Risk in Communities Study. Br. J. Ophthalmol.91(4), 430–433 (2007).
   PubMed Web of Science ®Google Scholar
• Hu FB, Stampfer MJ, Manson JE et al. Dietary fat intake and the risk of coronary heart disease in women. N. Engl. J. Med.337(21), 1491–1499 (1997).
   PubMed Web of Science ®Google Scholar
• Chong EW, Sinclair AJ, Guymer RH. Facts on fats. Clin. Exp. Ophthalmol.34(5), 464–471 (2006).
   PubMedGoogle Scholar
• Vingerling JR, Dielemans I, Bots ML et al. Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am. J. Epidemiol.142(4), 404–409 (1995).
   PubMed Web of Science ®Google Scholar
• Mares-Perlman JA, Brady WE, Klein R et al. Dietary fat and age-related maculopathy. Arch. Ophthalmol.113(6), 743–748 (1995).
   PubMed Web of Science ®Google Scholar
• Smith W, Mitchell P, Leeder SR. Dietary fat and fish intake and age-related maculopathy. Arch. Ophthalmol.118(3), 401–404 (2000).
   PubMedGoogle Scholar
• Starita C, Hussain AA, Patmore A, Marshall J. Localization of the site of major resistance to fluid transport in Bruch’s membrane. Invest. Ophthalmol. Vis. Sci.38(3), 762–767 (1997).
   PubMed Web of Science ®Google Scholar
• Pauleikhoff D, Harper CA, Marshall J, Bird AC. Aging changes in Bruch’s membrane. A histochemical and morphologic study. Ophthalmology97(2), 171–178 (1990).
   PubMed Web of Science ®Google Scholar
• Pauleikhoff D, Zuels S, Sheraidah GS et al. Correlation between biochemical composition and fluorescein binding of deposits in Bruch’s membrane. Ophthalmology99(10), 1548–1553 (1992).
   PubMedGoogle Scholar
• Anderson DH, Mullins RF, Hageman GS, Johnson LV. A role for local inflammation in the formation of drusen in the aging eye. Am. J. Ophthalmol.134(3), 411–431 (2002).
   PubMed Web of Science ®Google Scholar
• Curcio CA, Millican CL, Bailey T, Kruth HS. Accumulation of cholesterol with age in human Bruch’s membrane. Invest. Ophthalmol. Vis. Sci.42(1), 265–274 (2001).
   PubMed Web of Science ®Google Scholar
• Malek G, Li CM, Guidry C et al. Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy. Am. J. Pathol.162(2), 413–425 (2003).
   PubMed Web of Science ®Google Scholar
• Anderson DH, Ozaki S, Nealon M et al. Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation. Am. J. Ophthalmol.131(6), 767–781 (2001).
   PubMed Web of Science ®Google Scholar
• Li CM, Chung BH, Presley JB et al. Lipoprotein-like particles and cholesteryl esters in human Bruch’s membrane: initial characterization. Invest. Ophthalmol. Vis. Sci.46(7), 2576–2586 (2005).
   PubMed Web of Science ®Google Scholar
• Potts AM. An hypothesis on macular disease. Trans. Am. Acad. Ophthalmol. Otolaryngol.70(6), 1058–1062 (1966).
   PubMedGoogle Scholar
• Schmidt S, Saunders AM, De La Paz MA et al. Association of the apolipoprotein E gene with age-related macular degeneration: possible effect modification by family history, age, and gender. Mol. Vis.6, 287–293 (2000).
   PubMed Web of Science ®Google Scholar
• Simonelli F, Margaglione M, Testa F et al. Apolipoprotein E polymorphisms in age-related macular degeneration in an Italian population. Ophthalmic. Res.33(6), 325–328 (2001).
   PubMed Web of Science ®Google Scholar
• Zareparsi S, Reddick AC, Branham KE et al. Association of apolipoprotein E alleles with susceptibility to age-related macular degeneration in a large cohort from a single center. Invest. Ophthalmol. Vis. Sci.45(5), 1306–1310 (2004).
   PubMed Web of Science ®Google Scholar
• Kliffen M, Lutgens E, Daemen MJ et al. The APO(*)E3-Leiden mouse as an animal model for basal laminar deposit. Br. J. Ophthalmol.84(12), 1415–1419 (2000).
   PubMed Web of Science ®Google Scholar
• Dithmar S, Curcio CA, Le NA et al. Ultrastructural changes in Bruch’s membrane of apolipoprotein E-deficient mice. Invest. Ophthalmol. Vis. Sci.41(8), 2035–2042 (2000).
   PubMed Web of Science ®Google Scholar
• Lee SJ, Kim JH, Chung MJ et al. Human apolipoprotein E2 transgenic mice show lipid accumulation in retinal pigment epithelium and altered expression of VEGF and bFGF in the eyes. J. Microbiol. Biotechnol.17(6), 1024–1030 (2007).
   PubMed Web of Science ®Google Scholar
• Kris-Etherton PM, Taylor DS, Yu-Poth S et al. Polyunsaturated fatty acids in the food chain in the United States. Am. J. Clin. Nutr.71(1 Suppl.), 179S–188S (2000).
   PubMed Web of Science ®Google Scholar
• Holub BJ. Clinical nutrition: 4. Omega-3 fatty acids in cardiovascular care. CMAJ166(5), 608–615 (2002).
   PubMed Web of Science ®Google Scholar
• Simopoulos AP, Leaf A, Salem N, Jr. Workshop on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. J. Am. Coll. Nutr.18(5), 487–489 (1999).
   PubMedGoogle Scholar
• Sperling RI, Robin JL, Kylander KA et al. The effects of N-3 polyunsaturated fatty acids on the generation of platelet-activating factor-acether by human monocytes. J. Immunol.139(12), 4186–4191 (1987).
   PubMed Web of Science ®Google Scholar
• Cho E, Hung S, Willett WC et al. Prospective study of dietary fat and the risk of age-related macular degeneration. Am. J. Clin. Nutr.73(2), 209–218 (2001).
   PubMed Web of Science ®Google Scholar
• Heuberger RA, Mares-Perlman JA, Klein R et al. Relationship of dietary fat to age-related maculopathy in the Third National Health and Nutrition Examination Survey. Arch. Ophthalmol.119(12), 1833–1838 (2001).
   PubMedGoogle Scholar
• SanGiovanni JP, Chew EY, Clemons TE et al. The relationship of dietary lipid intake and age-related macular degeneration in a case–control study: AREDS Report No. 20. Arch. Ophthalmol.125(5), 671–679 (2007).
   PubMed Web of Science ®Google Scholar
• Stinson AM, Wiegand RD, Anderson RE. Recycling of docosahexaenoic acid in rat retinas during n-3 fatty acid deficiency. J. Lipid Res.32(12), 2009–2017 (1991).
   PubMed Web of Science ®Google Scholar
• Stone WL, Farnsworth CC, Dratz EA. A reinvestigation of the fatty acid content of bovine, rat and frog retinal rod outer segments. Exp. Eye Res.28(4), 387–397 (1979).
   PubMed Web of Science ®Google Scholar
• Reme CE, Malnoe A, Jung HH et al. Effect of dietary fish oil on acute light-induced photoreceptor damage in the rat retina. Invest. Ophthalmol. Vis. Sci.35(1), 78–90 (1994).
   PubMed Web of Science ®Google Scholar
• Smith DP, Ranganathan R, Hardy RW et al. Photoreceptor deactivation and retinal degeneration mediated by a photoreceptor-specific protein kinase C. Science254(5037), 1478–1484 (1991).
   PubMed Web of Science ®Google Scholar
• Seddon JM, Gensler G, Klein ML, Milton RC. C-reactive protein and homocysteine are associated with dietary and behavioral risk factors for age-related macular degeneration. Nutrition22(4), 441–443 (2006).
   PubMedGoogle Scholar
• Chen W, Esselman WJ, Jump DB, Busik JV. Anti-inflammatory effect of docosahexaenoic acid on cytokine-induced adhesion molecule expression in human retinal vascular endothelial cells. Invest. Ophthalmol. Vis. Sci.46(11), 4342–4347 (2005).
   PubMed Web of Science ®Google Scholar
• Chen W, Jump DB, Esselman WJ, Busik JV. Inhibition of cytokine signaling in human retinal endothelial cells through modification of caveolae/lipid rafts by docosahexaenoic acid. Invest. Ophthalmol. Vis. Sci.48(1), 18–26 (2007).
   PubMed Web of Science ®Google Scholar
• Connor KM, SanGiovanni JP, Lofqvist C et al. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat. Med.13(7), 868–873 (2007).
   PubMed Web of Science ®Google Scholar
• German OL, Miranda GE, Abrahan CE, Rotstein NP. Ceramide is a mediator of apoptosis in retina photoreceptors. Invest. Ophthalmol. Vis. Sci.47(4), 1658–1668 (2006).
   PubMedGoogle Scholar
• German OL, Insua MF, Gentili C et al. Docosahexaenoic acid prevents apoptosis of retina photoreceptors by activating the ERK/MAPK pathway. J. Neurochem.98(5), 1507–1520 (2006).
   PubMed Web of Science ®Google Scholar
• Elner VM. Retinal pigment epithelial acid lipase activity and lipoprotein receptors: effects of dietary omega-3 fatty acids. Trans. Am. Ophthalmol. Soc.100, 301–338 (2002).
   PubMedGoogle Scholar
• Johnson EJ. Obesity, lutein metabolism, and age-related macular degeneration: a web of connections. Nutr. Rev.63(1), 9–15 (2005).
   PubMed Web of Science ®Google Scholar
• Schaumberg DA, Christen WG, Hankinson SE, Glynn RJ. Body mass index and the incidence of visually significant age-related maculopathy in men. Arch. Ophthalmol.119(9), 1259–1265 (2001).
   PubMedGoogle Scholar
• Smith W, Mitchell P, Leeder SR, Wang JJ. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch. Ophthalmol.116(5), 583–587 (1998).
   PubMed Web of Science ®Google Scholar
• Delcourt C, Michel F, Colvez A et al. Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study. Ophthalmic Epidemiol.8(4), 237–249 (2001).
   PubMedGoogle Scholar
• Clemons TE, Milton RC, Klein R et al. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology112(4), 533–539 (2005).
   PubMed Web of Science ®Google Scholar
• Klein BE, Klein R, Lee KE, Jensen SC. Measures of obesity and age-related eye diseases. Ophthalmic Epidemiol.8(4), 251–262 (2001).
   PubMedGoogle Scholar
• Seddon JM, George S, Rosner B, Klein ML. CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum. Hered.61(3), 157–165 (2006).
   PubMed Web of Science ®Google Scholar
• Francis PJ, George S, Schultz DW et al. The LOC387715 gene, smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum. Hered.63(3–4), 212–218 (2007).
   PubMedGoogle Scholar
• Seddon JM, Francis PJ, George S et al. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA297(16), 1793–1800 (2007).
   PubMed Web of Science ®Google Scholar
• Anderson GJ, Connor WE, Corliss JD. Docosahexaenoic acid is the preferred dietary n-3 fatty acid for the development of the brain and retina. Pediatr. Res.27(1), 89–97 (1990).
   PubMed Web of Science ®Google Scholar
• Keaney JF, Jr., Larson MG, Vasan RS et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler. Thromb. Vasc. Biol.23(3), 434–439 (2003).
   PubMed Web of Science ®Google Scholar
• Anderson RE, Maude MB, Lewis RA et al. Abnormal plasma levels of polyunsaturated fatty acid in autosomal dominant retinitis pigmentosa. Exp. Eye Res.44(1), 155–159 (1987).
   PubMedGoogle Scholar
• Anderson RE, O’Brien PJ, Wiegand RD et al. Conservation of docosahexaenoic acid in the retina. Adv. Exp. Med. Biol.318, 285–294 (1992).
   PubMedGoogle Scholar
• Bazan NG. Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection. Curr. Opin. Clin. Nutr. Metab. Care10(2), 136–141 (2007).
   PubMed Web of Science ®Google Scholar
• Bell SJ, Chavali S, Bistrian BR et al. Dietary fish oil and cytokine and eicosanoid production during human immunodeficiency virus infection. JPEN J. Parenter. Enteral. Nutr.20(1), 43–49 (1996).
   PubMedGoogle Scholar
• Berson EL, Rosner B, Sandberg MA et al. Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment. Arch. Ophthalmol.122(9), 1297–1305 (2004).
   PubMedGoogle Scholar
• Birkle DL, Bazan NG. Lipoxygenase- and cyclooxygenase-reaction products and incorporation into glycerolipids or radiolabeled arachidonic acid in the bovine retina. Prostaglandins27(2), 203–216 (1984).
   PubMed Web of Science ®Google Scholar
• Bone RA, Landrum JT, Tarsis SL. Preliminary identification of the human macular pigment. Vision Res.25(11), 1531–1535 (1985).
   PubMed Web of Science ®Google Scholar
• Bourre JM, Francois M, Youyou A et al. The effects of dietary α-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rats. J. Nutr.119(12), 1880–1892 (1989).
   PubMed Web of Science ®Google Scholar
• Warburton DE, Nicol CW, Bredin SS. Health benefits of physical activity: the evidence. CMAJ174(6), 801–809 (2006).
   PubMed Web of Science ®Google Scholar
• Kraus WE, Houmard JA, Duscha BD et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N. Engl. J. Med.347(19), 1483–1492 (2002).
   PubMed Web of Science ®Google Scholar
• Hu FB, Stampfer MJ, Colditz GA et al. Physical activity and risk of stroke in women. JAMA283(22), 2961–2967 (2000).
   PubMed Web of Science ®Google Scholar
• Tanasescu M, Leitzmann MF, Rimm EB et al. Exercise type and intensity in relation to coronary heart disease in men. JAMA288(16), 1994–2000 (2002).
   PubMed Web of Science ®Google Scholar
• Knudtson MD, Klein R, Klein BE. Physical activity and the 15-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Br. J. Ophthalmol.90(12), 1461–1463 (2006).
   PubMedGoogle Scholar
• Klein R, Klein BE, Tomany SC, Cruickshanks KJ. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology110(6), 1273–1280 (2003).
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Tomany SC, Cruickshanks KJ. Association of emphysema, gout, and inflammatory markers with long-term incidence of age-related maculopathy. Arch. Ophthalmol.121(5), 674–678 (2003).
   PubMedGoogle Scholar
• Hyman LG, Lilienfeld AM, Ferris FL 3rd, Fine SL. Senile macular degeneration: a case–control study. Am. J. Epidemiol.118(2), 213–227 (1983).
   PubMed Web of Science ®Google Scholar
• Rimm EB, Klatsky A, Grobbee D, Stampfer MJ. Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits. BMJ312(7033), 731–736 (1996).
   PubMed Web of Science ®Google Scholar
• Mukamal KJ, Conigrave KM, Mittleman MA et al. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N. Engl. J. Med.348(2), 109–118 (2003).
   PubMed Web of Science ®Google Scholar
• Agar E, Demir S, Amanvermez R et al. The effects of ethanol consumption on the lipid peroxidation and glutathione levels in the right and left brains of rats. Int. J. Neurosci.113(12), 1643–1652 (2003).
   PubMed Web of Science ®Google Scholar
• Cederbaum AI. Role of lipid peroxidation and oxidative stress in alcohol toxicity. Free Radic. Biol. Med.7(5), 537–539 (1989).
   PubMed Web of Science ®Google Scholar
• Jakubowski JA, Vaillancourt R, Deykin D. Interaction of ethanol, prostacyclin, and aspirin in determining human platelet reactivity in vitro. Arteriosclerosis8(4), 436–441 (1988).
   PubMedGoogle Scholar
• Hendriks HF, Veenstra J, Velthuis-te Wierik EJ et al. Effect of moderate dose of alcohol with evening meal on fibrinolytic factors. BMJ308(6935), 1003–1006 (1994).
   PubMed Web of Science ®Google Scholar
• Ridker PM, Vaughan DE, Stampfer MJ et al. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA272(12), 929–933 (1994).
   PubMed Web of Science ®Google Scholar
• Albert MA, Glynn RJ, Ridker PM. Alcohol consumption and plasma concentration of C-reactive protein. Circulation107(3), 443–447 (2003).
   PubMed Web of Science ®Google Scholar
• Levitan EB, Ridker PM, Manson JE et al. Association between consumption of beer, wine, and liquor and plasma concentration of high-sensitivity C-reactive protein in women aged 39 to 89 years. Am. J. Cardiol.96(1), 83–88 (2005).
   PubMed Web of Science ®Google Scholar
• Castelli WP, Doyle JT, Gordon T et al. Alcohol and blood lipids. The cooperative lipoprotein phenotyping study. Lancet2(8030), 153–155 (1977).
   PubMed Web of Science ®Google Scholar
• Rimm EB, Williams P, Fosher K et al. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ319(7224), 1523–1528 (1999).
   PubMed Web of Science ®Google Scholar
• Stewart SH. Alcohol and inflammation: a possible mechanism for protection against ischemic heart disease. Nutr. Metab. Cardiovasc. Dis.12(3), 148–151 (2002).
   PubMedGoogle Scholar
• Seddon JM, Gensler G, Milton RC et al. Association between C-reactive protein and age-related macular degeneration. JAMA291(6), 704–710 (2004).
   PubMed Web of Science ®Google Scholar
• Chong EW, Kreis AJ, Wong TY et al. Alcohol consumption and the risk of age-related macular degeneration: a systematic review and meta-analysis. Am. J. Ophthalmol.145(4), 707–715 (2008).
   PubMed Web of Science ®Google Scholar
• Katz ML, Parker KR, Handelman GJ et al. Effects of antioxidant nutrient deficiency on the retina and retinal pigment epithelium of albino rats: a light and electron microscopic study. Exp. Eye Res.34(3), 339–369 (1982).
   PubMed Web of Science ®Google Scholar
• Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, β carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch. Ophthalmol.119(10), 1417–1436 (2001).
   PubMed Web of Science ®Google Scholar
• Brady WE, Mares-Perlman JA, Bowen P, Stacewicz-Sapuntzakis M. Human serum carotenoid concentrations are related to physiologic and lifestyle factors. J. Nutr.126(1), 129–137 (1996).
   PubMed Web of Science ®Google Scholar
• Bora PS, Kaliappan S, Xu Q et al. Alcohol linked to enhanced angiogenesis in rat model of choroidal neovascularization. FEBS J.273(7), 1403–1414 (2006).
   PubMed Web of Science ®Google Scholar
• Ham WT Jr, Mueller HA, Sliney DH. Retinal sensitivity to damage from short wavelength light. Nature260(5547), 153–155 (1976).
   PubMed Web of Science ®Google Scholar
• Taylor HR, West S, Munoz B et al. The long-term effects of visible light on the eye. Arch. Ophthalmol.110(1), 99–104 (1992).
   PubMed Web of Science ®Google Scholar
• Cruickshanks KJ, Klein R, Klein BE. Sunlight and age-related macular degeneration. The Beaver Dam Eye Study. Arch. Ophthalmol.111(4), 514–518 (1993).
   PubMed Web of Science ®Google Scholar
• Tomany SC, Cruickshanks KJ, Klein R et al. Sunlight and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Arch. Ophthalmol.122(5), 750–757 (2004).
   PubMed Web of Science ®Google Scholar
• Delcourt C, Carriere I, Ponton-Sanchez A et al. Light exposure and the risk of age-related macular degeneration: the Pathologies Oculaires Liees a l’Age (POLA) study. Arch. Ophthalmol.119(10), 1463–1468 (2001).
   PubMedGoogle Scholar
• Darzins P, Mitchell P, Heller RF. Sun exposure and age-related macular degeneration. An Australian case–control study. Ophthalmology104(5), 770–776 (1997).
   PubMed Web of Science ®Google Scholar
• Glickman RD. Phototoxicity to the retina: mechanisms of damage. Int. J. Toxicol.21(6), 473–490 (2002).
   PubMed Web of Science ®Google Scholar
• Kirschfeld K. Carotenoid pigments: their possible role in protecting against photooxidation in eyes and photoreceptor cells. Proc. R Soc. Lond. B Biol. Sci.216(1202), 71–85 (1982).
   PubMed Web of Science ®Google Scholar
• Snodderly DM, Auran JD, Delori FC. The macular pigment. II. Spatial distribution in primate retinas. Invest. Ophthalmol. Vis. Sci.25(6), 674–685 (1984).
   PubMed Web of Science ®Google Scholar
• Snodderly DM. Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am. J. Clin. Nutr.62(6 Suppl.), 1448S–1461S (1995).
   PubMed Web of Science ®Google Scholar
• Jampol LM. Antioxidants and zinc to prevent progression of age-related macular degeneration. JAMA286(19), 2466–2468 (2001).
   Google Scholar
• Crabb JW, Miyagi M, Gu X et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc. Natl Acad. Sci. USA99(23), 14682–14687 (2002).
   PubMed Web of Science ®Google Scholar
• Chopdar A, Chakravarthy U, Verma D. Age related macular degeneration. BMJ326(7387), 485–488 (2003).
   PubMed Web of Science ®Google Scholar
• Hall NF, Gale CR. Prevention of age related macular degeneration. BMJ325(7354), 1–2 (2002).
   PubMedGoogle Scholar
• Mares JA, La Rowe TL, Blodi BA. Doctor, what vitamins should I take for my eyes? Arch. Ophthalmol.122(4), 628–635 (2004).
   PubMedGoogle Scholar
• Mares-Perlman JA, Millen AE, Ficek TL, Hankinson SE. The body of evidence to support a protective role for lutein and zeaxanthin in delaying chronic disease. Overview. J. Nutr.132(3), 518S–524S.(2002).
   PubMed Web of Science ®Google Scholar
• Chong EW, Wong TY, Kreis AJ et al. Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis. BMJ335(7623), 755 (2007).
   PubMed Web of Science ®Google Scholar
• Taylor HR, Tikellis G, Robman LD et al. Vitamin E supplementation and macular degeneration: randomised controlled trial. BMJ325(7354), 11 (2002).
   PubMed Web of Science ®Google Scholar
• Wilson HL, Schwartz DM, Bhatt HR et al. Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration. Am. J. Ophthalmol.137(4), 615–624 (2004).
   PubMed Web of Science ®Google Scholar
• McCarty CA, Mukesh BN, Guymer RH et al. Cholesterol-lowering medications reduce the risk of age-related maculopathy progression. Med. J. Aust.175(6), 340 (2001).
   PubMed Web of Science ®Google Scholar
• Hall NF, Gale CR, Syddall H et al. Risk of macular degeneration in users of statins: cross sectional study. BMJ323(7309), 375–376 (2001).
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Tomany SC et al. Relation of statin use to the 5-year incidence and progression of age-related maculopathy. Arch. Ophthalmol.121(8), 1151–1155 (2003).
   PubMed Web of Science ®Google Scholar
• van Leeuwen R, Tomany SC, Wang JJ et al. Is medication use associated with the incidence of early age-related maculopathy? Pooled findings from 3 continents. Ophthalmology111(6), 1169–1175 (2004).
   PubMed Web of Science ®Google Scholar
• Tan JS, Mitchell P, Rochtchina E, Wang JJ. Statins and the long-term risk of incident age-related macular degeneration: the Blue Mountains Eye Study. Am. J. Ophthalmol.143(4), 685–687 (2007).
   PubMed Web of Science ®Google Scholar
• Klein R, Knudtson MD, Klein BE. Statin use and the five-year incidence and progression of age-related macular degeneration. Am. J. Ophthalmol.144(1), 1–6 (2007).
   PubMed Web of Science ®Google Scholar
• Rader DJ, Maugeais C. Genes influencing HDL metabolism: new perspectives and implications for atherosclerosis prevention. Mol. Med. Today6(4), 170–175 (2000).
   PubMedGoogle Scholar
• Penfold PL, Madigan MC, Gillies MC, Provis JM. Immunological and aetiological aspects of macular degeneration. Prog. Retin. Eye Res.20(3), 385–414 (2001).
   PubMed Web of Science ®Google Scholar
• Jialal I, Stein D, Balis D et al. Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels. Circulation103(15), 1933–1935 (2001).
   PubMed Web of Science ®Google Scholar
• Ridker PM, Rifai N, Pfeffer MA et al. Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation100(3), 230–235 (1999).
   PubMed Web of Science ®Google Scholar
• Hageman GS, Luthert PJ, Victor Chong NH et al. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch’s membrane interface in aging and age-related macular degeneration. Prog. Retin. Eye Res.20(6), 705–732 (2001).
   PubMed Web of Science ®Google Scholar
• Spaide RF, Ho-Spaide WC, Browne RW, Armstrong D. Characterization of peroxidized lipids in Bruch’s membrane. Retina19(2), 141–147 (1999).
   PubMed Web of Science ®Google Scholar
• Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler. Thromb. Vasc. Biol.21(11), 1712–1719 (2001).
   PubMed Web of Science ®Google Scholar
• Plantner JJ, Jiang C, Smine A. Increase in interphotoreceptor matrix gelatinase A (MMP-2) associated with age-related macular degeneration. Exp. Eye Res.67(6), 637–645 (1998).
   PubMed Web of Science ®Google Scholar
• Guymer R, Varsamidis M, Dimitrov P et al. Can HMG Co-A Reductase inhibitors (‘statins’) slow the progression of age-related macular degeneration? The Age-Related Maculopathy Statin Study (ARMSS). Clin. Interv. Aging3(3) 581–593 (2008).
   PubMed Web of Science ®Google Scholar
• Chong EW, Kreis AJ, Wong TY et al. Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. Arch. Ophthalmol.126(6), 826–833 (2008).
   PubMedGoogle Scholar
• Seddon J, Ajani U, Sperduto R et al. Dietary fat intake and age-related macular degeneration (ARVO, abstract 3454a). Invest. Ophthalmol. Vis. Sci.35, 2003 (1994).
   Google Scholar
• Chua B, Flood V, Rochtchina E, Wang JJ, Smith W, Mitchell P. Dietary fatty acids and the 5 year incidence of age-related maculopathy. Arch. Ophthalmol.124(7), 981–986 (2006).
   PubMedGoogle Scholar
• Delcourt C, Carriere I, Cristol JP, Lacroux A, Gerber M. Dietary fat and the risk of age-related maculopathy: the POLANUT Study. Eur. J. Clin. Nutr.61(11), 1341–1344 (2007).
   PubMed Web of Science ®Google Scholar
• Arnarsson A, Sverrisson T, Stefansson E et al. Risk factors for five-year incident age-related macular degeneration: the Reykjavik Eye Study. Am. J. Ophthalmol.142(3), 419–428 (2006).
   PubMedGoogle Scholar
• Ajani UA, Christen WG, Manson JE et al. A prospective study of alcohol consumption and the risk of age-related macular degeneration. Ann. Epidemiol.9, 172–177 (1999).
   PubMed Web of Science ®Google Scholar
• Buch H, Vinding T, la Cour M, Jensen GB, Prause JU, Nielsen NV. Risk factors for age-related maculopathy in a 14 year follow-up study: the Copenhagen City Eye Study. Acta Ophthalmol. Scand.83, 409–418 (2005).
   PubMedGoogle Scholar
• Cho E, Hankinson SE, Willett WC et al. Prospective study of alcohol consumption and the risk of age-related macular degeneration. Arch. Ophthalmol.118, 681–688 (2000).
   PubMed Web of Science ®Google Scholar
• Knudtson MD, Klein R, Klein BE. Alcohol consumption and the 15 year cumulative incidence of age-related macular degeneration. Am. J. Ophthalmol.143, 1026–1029 (2007).
   PubMed Web of Science ®Google Scholar
• Flood V, Smith W, Wang JJ, Manzi F, Webb K, Mitchell P. Dietary antioxidant intake and incidence of early age-related maculopathy: the Blue Mountains Eye Study. Ophthalmology109(12), 2272–2278 (2002).
   PubMed Web of Science ®Google Scholar
• Cho E, Seddon JM, Rosner B, Willett WC, Hankinson SE. Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch. Ophthalmol.122(6), 883–892 (2004).
   PubMed Web of Science ®Google Scholar
• van Leeuwen R, Boekhoorn S, Vingerling JR et al. Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA294(24), 3101–3107 (2005).
   PubMed Web of Science ®Google Scholar
• Van den Langenberg GM, Mares-Perlman JA, Klein R, Klein BE, Brady WE, Palta M. Associations between antioxidant and zinc intake and the 5 year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am. J. Epidemiol.148(2), 204–214 (1998).
   PubMedGoogle Scholar
• Cho E, Stampfer MJ, Seddon JM et al. Prospective study of zinc intake and the risk of age-related macular degeneration. Ann. Epidemiol.11(5), 328–336 (2001).
   PubMedGoogle Scholar
• Chong EW, Robman LD, Simpson JA et al. The associations of dietary lutein, zeaxanthin and fats with age-related macular degeneration: the Melbourne Collaborative Cohort Study. Program and abstracts of the Association for Research in Vision and Ophthalmology. Fort Lauderdale, FL, USA, 30 April– 4 May 2006 (Abstract 1133).
   Google Scholar
• Flood V, Rochtchina E, Wang JJ, Mitchell P, Smith W. Lutein and zeaxanthin dietary intake and age related macular degeneration. Br. J. Ophthalmol.90(7), 927–928 (2006).
   PubMed Web of Science ®Google Scholar
• Moeller SM, Parekh N, Tinker L et al. Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease Study (CAREDS): ancillary study of the Women’s Health Initiative. Arch. Ophthalmol.124(8), 1151–1162 (2006).
   PubMed Web of Science ®Google Scholar